Resource Library
Showing 1 to 10 of 74 results
Image
Acute lymphoblastic leukemia (ALL) affects immature white blood cells called lymphoblasts and can progresses quickly without treatment. Dr. Dawn Maze, a member of the Leukemia Program and the Elizabeth and Tony Comper MPN Program at the Princess Margaret Cancer Centre, addresses treatment of acute lymphoblastic leukemia, advances in research and management…
Image
Chronic myeloid leukemia (CML) is a rare type of leukemia that can happen when cells that make the blood develop a genetic change called BCR-ABL1 (Philadelphia chromone). Dr. M. Lynn Savoie, hematologist at Tom Baker Cancer Centre in Calgary, Alberta, discusses treatment options, including hematopoiesis stem cell transplants, and ways to minimize side…
Image
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults and can vary from person to person. This is why a one-size-fits-all treatment approach is not optimal. Research advances in how we treat CLL are discussed by Dr. Anthea Peters, Hematologist at the Cross Cancer Institute in Edmonton, and Associate Professor, Department of…
Image
Acute myeloid leukemia (AML) is a type of cancer that forms in blood cells and bone marrow that progresses rapidly if untreated. In this presentation, Dr. Brett Houston, a hematologist at the University of Manitoba, will speak about her work in clinical trials in finding ways to optimize care and improve outcomes for patients affected with acute leukemia,…
Image
Chronic myeloid leukemia: a discussion with a survivor and an expert
Image
This webcast takes participants through today’s treatment options—from initial therapies to newer and more advanced approaches now available. The session highlights what patients can typically expect at each stage of treatment, including how decisions are made and how care is tailored to individual needs.
Image
Barry Yhard is a Lymphoma survivor currently employed with the Canadian Forces Health Services Group. He is certified by the Surgeon General as a mental health educator. Barry served for 33 years as an active member of the military but was injured in 2009 and in 2010 diagnosed with PTSD.
Image
Marell Tomeh was first diagnosed with ALL in April 2013 at age 19. Following the two-year Dana Farber Protocol, Marell was in remission for 3 years before relapsing in September 2018 at age 24. After an eventful and complicated journey to remission, Marell was finally able to receive a stem cell transplant in April 2019 at age 25.
Image
Meghan MacMillan is a Clinical Nurse Specialist in the Adolescent and Young Adult Program at Princess Margaret Cancer Centre. She helps support the care and specific needs of patients diagnosed with cancer between the ages of 18-39 years old.
Image
Hart is a non-Hodgkin lymphoma survivor and has been actively involved with the LLSC since 2011, primarily as a First Connection volunteer.